Cargando…
Using human induced pluripotent stem cells to treat retinal disease()
The eye is an ideal target for exploiting the potential of human induced pluripotent stem cell (hiPSC) technology in order to understand disease pathways and explore novel therapeutic strategies for inherited retinal disease. The aim of this article is to map the pathway from state-of-the art labora...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841575/ https://www.ncbi.nlm.nih.gov/pubmed/24104210 http://dx.doi.org/10.1016/j.preteyeres.2013.09.002 |
_version_ | 1782292803119742976 |
---|---|
author | Borooah, S. Phillips, M.J. Bilican, B. Wright, A.F. Wilmut, I. Chandran, S. Gamm, D. Dhillon, B. |
author_facet | Borooah, S. Phillips, M.J. Bilican, B. Wright, A.F. Wilmut, I. Chandran, S. Gamm, D. Dhillon, B. |
author_sort | Borooah, S. |
collection | PubMed |
description | The eye is an ideal target for exploiting the potential of human induced pluripotent stem cell (hiPSC) technology in order to understand disease pathways and explore novel therapeutic strategies for inherited retinal disease. The aim of this article is to map the pathway from state-of-the art laboratory-based discoveries to realising the translational potential of this emerging technique. We describe the relevance and routes to establishing hiPSCs in selected models of human retinal disease. Additionally, we define pathways for applying hiPSC technology in treating currently incurable, progressive and blinding retinal disease. |
format | Online Article Text |
id | pubmed-3841575 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Pergamon |
record_format | MEDLINE/PubMed |
spelling | pubmed-38415752013-11-27 Using human induced pluripotent stem cells to treat retinal disease() Borooah, S. Phillips, M.J. Bilican, B. Wright, A.F. Wilmut, I. Chandran, S. Gamm, D. Dhillon, B. Prog Retin Eye Res Article The eye is an ideal target for exploiting the potential of human induced pluripotent stem cell (hiPSC) technology in order to understand disease pathways and explore novel therapeutic strategies for inherited retinal disease. The aim of this article is to map the pathway from state-of-the art laboratory-based discoveries to realising the translational potential of this emerging technique. We describe the relevance and routes to establishing hiPSCs in selected models of human retinal disease. Additionally, we define pathways for applying hiPSC technology in treating currently incurable, progressive and blinding retinal disease. Pergamon 2013-11 /pmc/articles/PMC3841575/ /pubmed/24104210 http://dx.doi.org/10.1016/j.preteyeres.2013.09.002 Text en © 2013 The Authors https://creativecommons.org/licenses/by-nc-nd/3.0/ Open Access under CC BY-NC-ND 3.0 (https://creativecommons.org/licenses/by-nc-nd/3.0/) license |
spellingShingle | Article Borooah, S. Phillips, M.J. Bilican, B. Wright, A.F. Wilmut, I. Chandran, S. Gamm, D. Dhillon, B. Using human induced pluripotent stem cells to treat retinal disease() |
title | Using human induced pluripotent stem cells to treat retinal disease() |
title_full | Using human induced pluripotent stem cells to treat retinal disease() |
title_fullStr | Using human induced pluripotent stem cells to treat retinal disease() |
title_full_unstemmed | Using human induced pluripotent stem cells to treat retinal disease() |
title_short | Using human induced pluripotent stem cells to treat retinal disease() |
title_sort | using human induced pluripotent stem cells to treat retinal disease() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841575/ https://www.ncbi.nlm.nih.gov/pubmed/24104210 http://dx.doi.org/10.1016/j.preteyeres.2013.09.002 |
work_keys_str_mv | AT borooahs usinghumaninducedpluripotentstemcellstotreatretinaldisease AT phillipsmj usinghumaninducedpluripotentstemcellstotreatretinaldisease AT bilicanb usinghumaninducedpluripotentstemcellstotreatretinaldisease AT wrightaf usinghumaninducedpluripotentstemcellstotreatretinaldisease AT wilmuti usinghumaninducedpluripotentstemcellstotreatretinaldisease AT chandrans usinghumaninducedpluripotentstemcellstotreatretinaldisease AT gammd usinghumaninducedpluripotentstemcellstotreatretinaldisease AT dhillonb usinghumaninducedpluripotentstemcellstotreatretinaldisease |